Impaired metoclopramide-induced pituitary prolactin release in men with human immunodeficiency virus infection

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 1, 1999, Pages 70-74

  Parra, Adalberto ^a,b,c,d,e   Ramírez Peredo, Jorge ^a,b,c,d,e   Coutiño, Blanca ^a,b,c,d,e   Lagunes, Bernadette ^a,b,c,d,e   Marín, Antonio ^a,b,c,d,e   De Leon, Samuel Ponce ^a,b,c,d,e   Ruiz Argüelles, Guillermo J ^a,b,c,d,e  

^a INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

^b Laboratorios Clinicos de Puebla   (Mexico)

^c SECRETARÍA DE SALUD   (Mexico)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^e Ctro Hematol Med Int de Puebla   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CONCENTRATION RESPONSE; HUMAN IMMUNODEFICIENCY VIRUS; HYPOPHYSIS; METOCLOPRAMIDE; PATHOGENESIS; PROLACTIN; RADIOIMMUNOASSAY; VIRUS INFECTION; WESTERN BLOTTING;

EID: 0032923332     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1053/lc.1999.v133.a94237     Document Type: Article

References (29)

1. 1. Dluhy RG. The growing spectrum of HIV-related endocrine abnormalities. J Clin Endocrinol Metab 1990;70:563-5.
2. 2. Grinspoon SK, Bilezikian JP. HIV disease and the endocrine system. N Engl J Med 1992;327:1360-5.
3. 3. Sellmeyer DE, Grunfeld C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev 1996; 17:518-32.
4. 4. Dobs S, Dempsey MA, Ladenson PW, Paul M. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med 1988;84:611-6.
5. 5. Chernow B, Schooley RT, Dracup K, Napolitano LM, Stanford GG, Klibanski A. Serum prolactin concentrations in patients with acquired immunodeficiency syndrome. Crit Care Med 1990;18:440-1.
6. 6. Merenich JA, McDermott MT, Asp AA, Harrison SM, Kidd GS. Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J Clin Endocrinol Metab 1990;70:566-71.
7. 7. Gorman JM, Warne PA, Begg MD, Cooper TB, Novacenko H, Williams JB, et al. Serum prolactin levels in homosexual and bisexual men with HIV infection. Am J Psychiatry 1992;149(suppl 3):367-70.
8. 8. Croxon TS, Chapman WE, Miller LK, Levit CD, Senie R, Zumoff B. Changes in the hypothalamic-pituitary-gonadal axis in human immunodeficiency virus-infected homosexual men. J Clin Endocrinol Metabol 1989;68:317-21.
9. 9. Graef AS, Gonzalez SS, Baca VR, Ramírez ML, Daza LB, Blanco FF, et al. High serum proiactin levels in asymptomatic HlV-infected patients and in patients with acquired immunodeficiency syndrome. Clin Immunol Immunopathol 1994;149(suppl3):390-3.
10. 10. Verges B, Chavanet P, Desgres J, Kisterman JP, Waldner A, Vaillant G, et al. Endocrine abnormalities in HIV infections. Presse Med 1990;19:1267-70.
11. 11. Wilson LD, Truong MP, Barber AR, Aoki TT. Anterior pituitary and pituitary-dependent target organ function in men infected with the human immunodeficiency virus. Metabolism 1996;45(suppl 6):738-46.
12. 12. McMurray RW, Allen SH, Braun AL, Rodríguez F, Walker SE. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumutol 1994;21:843-50.
13. 13. Murphy WJ, Rui H, Longo DL. Effects of growth hormone and prolactin immune development and function. Life Sci 1995;57:1-14.
14. 14. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 1996;17:639-69.
15. 15. Clark R. The somatogenic hormones and insulin-like growth factor-1 : stimulators of lymphopoiesis and immune function. Endoer Rev 1997;18:157-79.
16. 16. Gerli R, Ricardi C, Nicoletti I, Orlandi S, Cernetti C, Spinozzi F, et al. Phenotypic and functional abnormalities of T lymphocytes in pathological hyperprolactinemia. J Clin Immunol 1987;7:463-70.
17. 17. López-Karpovitch X, Larrea F, Cárdenas R, Valencia X, Piedras J, Díaz-Sánchez V, et al. Cellular and humoral immune parameters in women with pathological hyperprolactinemia before and during treatment with bromocryptine. Am J Reprod Immunol 1994;31:32-9.
18. 18. Berczi I. Prolactin, pregnancy and autoimmune disease. J Rheumatol 1993;20:1095-100.
19. 19. Larrea F, Martínez-Castillo A, Cabrera V, Alcocer-Varela J, Queipo G, Cariño C, et al. A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and non-stimulated peripheral blood mononuclear cells from subjects with systemic lupus crythematosus. J Clin Endocrinol Metab 1997;82:3664-9.
20. 20. Ruiz-Argüelles A. Flow cytometry in the clinical laboratory. Principles, applications and problems. Clin Chim Acta 1992;211:513-27.
21. 21. Centers for Disease Control 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41(RR-17):1-19.
22. 22. Knupp CA, Milbrath RL, Barbhaiya RH. The effect of metoclopramide and loperamide on the pharmacokinetics of didanosine in HIV seropositive asymptomatic male and female patients. Eur J Clin Pharmacol 1993;45:409-13.
23. 23. Zenobi PD, Jaeggi-Groisman SE, Riesen WF, Roder ME, Froesch ER. Insulin-like growth factor-1 improves glucose and lipid metabolism in type 2 diabetes mellitus. J Clin Invest 1992;90:2234-41.
24. 24. Beeker DJ, Vinick AI, Pimstone BL, Paul M. Prolactin responses to thyrotropin-releasing hormone in protein-calorie malnutrition. J Clin Endocrinol Metab 1975;41:782-3.
25. 25. Medeiros-Neto GA, Sucupira M, Knobel M, Cintra AU. PRL, TSH and thyroid hormone responses to TRH in adult protein calorie malnutrition. Horm Metab Res 1977;9:524-5.
26. 26. Quigley ME, Judd SJ, Gilliland GB, Yen SSC. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and in women with hyperprolactinemic anovulation. J Clin Endocrinol Metab 1979;48:718-20.
27. 27. Birnbacher R, Scheibenreiter S, Blau N, Bieglmayer C, Frisch H, Waldhauser F. Hyperprolactinemia, a tool in treatment control of tetrahydrobiopterin deficiency: endocrine studies in an affected girl. Pediatr Res 1998;43:472-7.
28. 28. Parra A, Barrón J, Marín VA, Coutiño B, Belmont J, Coria I. Acute dopaminergic blockade augments the naloxoneinduced LH rise in estrogen-treated postmenopausal women. Maturitas 1997;27:91-9.
29. 29. Berger JR, Kumar M, Kumar A, Fernánden JB, Levin B. Cerebrospinal fluid dopamine in HIV-1 infection. AIDS 1994;8:67-71.